We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
Cap. Flow
+$29.6M
Cap. Flow %
3.15%
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$5.37M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.7M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.54M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$2.12M
5
NVDA icon
NVIDIA
NVDA
+$1.88M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.88M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$4.62M
3
OCSL icon
Oaktree Specialty Lending
OCSL
+$825K
4
MGI
MoneyGram International, Inc. New
MGI
+$627K
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$562K

Sector Composition

Rank Sector Weight
1 Financials 16.18%
2 Technology 15.3%
3 Healthcare 6.27%
4 Consumer Discretionary 3.61%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCKT icon
2201
Rocket Pharmaceuticals
RCKT
$394M
$1.75K ﹤0.01%
88
– –
QDEL icon
2202
QuidelOrtho
QDEL
$838M
$1.74K ﹤0.01%
21
-32
-60% -$2.8K
HNST icon
2203
The Honest Company
HNST
$586M
$1.74K ﹤0.01%
1,035
+34
+3% +$58
NRIX icon
2204
Nurix Therapeutics
NRIX
$2.65B
$1.74K ﹤0.01%
174
-129
-43% -$1.32K
ALIT icon
2205
Alight
ALIT
$407M
$1.74K ﹤0.01%
+9
New +$1.6K
NGD
2206
DELISTED
New Gold Inc
NGD
$1.73K ﹤0.01%
1,602
– –
TSEM icon
2207
Tower Semiconductor
TSEM
$28.5B
$1.73K ﹤0.01%
46
– –
MYPS icon
2208
PLAYSTUDIOS Inc
MYPS
$90.1M
$1.72K ﹤0.01%
+350
New +$1.53K
PLPC icon
2209
Preformed Line Products
PLPC
$2.28B
$1.72K ﹤0.01%
11
– –
MCRB icon
2210
Seres Therapeutics
MCRB
$48.4M
$1.7K ﹤0.01%
18
-5
-22% -$544
TARS icon
2211
Tarsus Pharmaceuticals
TARS
$2.84B
$1.7K ﹤0.01%
+94
New +$1.49K
REZI icon
2212
Resideo Technologies
REZI
$3.95B
$1.7K ﹤0.01%
96
+31
+48% +$535
NUVB icon
2213
Nuvation Bio
NUVB
$2.32B
$1.69K ﹤0.01%
941
+777
+474% +$1.32K
CMAX
2214
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$1.69K ﹤0.01%
18
-7
-28% -$617
WOOF icon
2215
Petco
WOOF
$794M
$1.68K ﹤0.01%
189
-90
-32% -$828
AMCR icon
2216
Amcor
AMCR
$22.1B
$1.68K ﹤0.01%
34
– –
MNKD icon
2217
MannKind Corp
MNKD
$1.32B
$1.68K ﹤0.01%
412
– –
COOP
2218
DELISTED
Mr. Cooper
COOP
$1.67K ﹤0.01%
33
+13
+65% +$596
MGRC icon
2219
McGrath RentCorp
MGRC
$2.92B
$1.67K ﹤0.01%
18
– –
FNDE icon
2220
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.81B
$1.66K ﹤0.01%
62
– –
TSVT
2221
DELISTED
2seventy bio
TSVT
$1.66K ﹤0.01%
+164
New +$1.74K
CGEM icon
2222
Cullinan Oncology
CGEM
$1.14B
$1.66K ﹤0.01%
154
-233
-60% -$2.48K
THO icon
2223
Thor Industries
THO
$4.14B
$1.66K ﹤0.01%
16
-18
-53% -$1.52K
SHEN icon
2224
Shenandoah Telecom
SHEN
$746M
$1.65K ﹤0.01%
85
-123
-59% -$2.41K
RH icon
2225
RH
RH
$3.71B
$1.65K ﹤0.01%
5
-1
-17% -$261
87 88
89
90 91

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.

  • Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
  • Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
  • Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
  • Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
  • Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.